Literature DB >> 15716520

Involvement of the peripheral nervous system in human prion diseases including dural graft associated Creutzfeldt-Jakob disease.

C Ishida1, S Okino, T Kitamoto, M Yamada.   

Abstract

OBJECTIVE: To investigate abnormal prion protein (PrP) deposition in the peripheral nervous system (PNS) in human prion diseases.
METHODS: Eight patients with prion diseases were examined: three with sporadic Creutzfeldt-Jakob disease (sCJD), two with dural graft associated CJD (dCJD), one with Gerstmann-Straussler-Scheinker disease (GSS) with a PrP P102L mutation (GSS102), and two with a P105L mutation (GSS105). An atypical case of sCJD with PrP plaques in the brain presented clinically with peripheral neuropathy, and showed demyelination in 12% of the teased fibres of the sural nerve. The PNS was investigated by immunohistochemical and western blotting analyses of PrP.
RESULTS: In immunohistochemical studies, granular PrP deposits were detected in some neurones of dorsal root ganglia and a few fibres of peripheral nerves and spinal posterior roots in one sCJD and two dCJD patients, but not in GSS102 or GSS105 patients. The atypical case of sCJD with peripheral neuropathy showed no obvious PrP deposition in the nerves. Western blotting analysis of the PNS from the dCJD patients revealed a small amount of protease K resistant PrP in the dorsal root ganglia and peripheral nerves.
CONCLUSIONS: Abnormal PrP deposition occurs in the dorsal root ganglia and peripheral nerves in sCJD and dCJD. The PrP deposits in the PNS are not correlated with clinical manifestation of peripheral neuropathy in CJD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15716520      PMCID: PMC1739566          DOI: 10.1136/jnnp.2003.035154

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  33 in total

1.  Creutzfeldt-Jakob disease after Jannetta's operation with cadaveric dura mater graft: initial manifestations related to the grafted site.

Authors:  Y Nishida; M Yamada; K Hara; T Tsunemi; M Yamawaki; R Shimokawa; R Okeda; T Tsutsumi; H Mizusawa
Journal:  J Neurol       Date:  2002-04       Impact factor: 4.849

Review 2.  Amyotrophy in prion diseases.

Authors:  B B Worrall; L P Rowland; S S Chin; J A Mastrianni
Journal:  Arch Neurol       Date:  2000-01

3.  Atypical form of dural graft associated Creutzfeldt-Jakob disease: report of a postmortem case with review of the literature.

Authors:  K Kimura; A Nonaka; H Tashiro; M Yaginuma; R Shimokawa; R Okeda; M Yamada
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-05       Impact factor: 10.154

4.  Deposition of disease-associated prion protein involves the peripheral nervous system in experimental scrapie.

Authors:  M H Groschup; M Beekes; P A McBride; M Hardt; J A Hainfellner; H Budka
Journal:  Acta Neuropathol       Date:  1999-11       Impact factor: 17.088

Review 5.  An inherited prion disease with a PrP P105L mutation: clinicopathologic and PrP heterogeneity.

Authors:  M Yamada; Y Itoh; A Inaba; Y Wada; M Takashima; S Satoh; T Kamata; R Okeda; T Kayano; N Suematsu; T Kitamoto; E Otomo; M Matsushita; H Mizusawa
Journal:  Neurology       Date:  1999-07-13       Impact factor: 9.910

Review 6.  Pathology of variant Creutzfeldt-Jakob disease.

Authors:  J W Ironside
Journal:  Arch Virol Suppl       Date:  2000

7.  [A case of Gerstmann-Sträussler-Scheinker syndrome (GSS) with late onset--a haplotype analysis of Glu219Lys polymorphism in PrP gene].

Authors:  K Takase; H Furuya; H Murai; T Yamada; Y Oh-yagi; K Doh-ura; T Iwaki; S Tobimatsu; J Kira
Journal:  Rinsho Shinkeigaku       Date:  2001-06

8.  Sporadic Creutzfeldt-Jakob disease with MM1-type prion protein and plaques.

Authors:  C Ishida; A Kakishima; S Okino; Y Furukawa; M Kano; Y Oda; I Nakanishi; T Makifuchi; T Kitamoto; M Yamada
Journal:  Neurology       Date:  2003-02-11       Impact factor: 9.910

9.  Impairment of the peripheral nervous system in Creutzfeldt-Jakob disease.

Authors:  Maria Niewiadomska; Jerzy Kulczycki; Danuta Wochnik-Dyjas; Grazyna M Szpak; Maria Rakowicz; Wanda Łojkowska; Krystyna Niedzielska; Ewa Inglot; Malgorzata Wieclawska; Czeslaw Glazowski; Eugenia Tarnowska-Dziduszko
Journal:  Arch Neurol       Date:  2002-09

10.  The sympathetic nervous system is involved in variant Creutzfeldt-Jakob disease.

Authors:  Stéphane Haïk; Baptiste A Faucheux; Véronique Sazdovitch; Nicolas Privat; Jean-Louis Kemeny; Armand Perret-Liaudet; Jean-Jacques Hauw
Journal:  Nat Med       Date:  2003-08-24       Impact factor: 53.440

View more
  8 in total

1.  Severe and rapidly evolving peripheral neuropathy revealing sporadic Creutzfeldt-Jakob disease.

Authors:  Hélène Zéphir; Tanya Stojkovic; Jérome de Seze; Claude-Alain Maurage; Katell Peoc'h; Stéphane Haïk; Patrick Vermersch
Journal:  J Neurol       Date:  2009-02-07       Impact factor: 4.849

2.  Bilayer oxidized regenerated cellulose/poly ε-caprolactone knitted fabric-reinforced composite for use as an artificial dural substitute.

Authors:  Jintamai Suwanprateeb; Ticomporn Luangwattanawilai; Thunyanun Theeranattapong; Waraporn Suvannapruk; Sorayouth Chumnanvej; Warinkarn Hemstapat
Journal:  J Mater Sci Mater Med       Date:  2016-06-09       Impact factor: 3.896

3.  Peripheral nervous system hyperexcitability in VV2 sporadic Creutzfeldt-Jakob disease.

Authors:  Charlene J Ong; Muhammad Al-Lozi; Patrick J Cimino; Robert Bucelli
Journal:  Neurol Clin Pract       Date:  2015-08

4.  The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6.

Authors:  Alexander Küffer; Asvin K K Lakkaraju; Amit Mogha; Sarah C Petersen; Kristina Airich; Cédric Doucerain; Rajlakshmi Marpakwar; Pamela Bakirci; Assunta Senatore; Arnaud Monnard; Carmen Schiavi; Mario Nuvolone; Bianka Grosshans; Simone Hornemann; Frederic Bassilana; Kelly R Monk; Adriano Aguzzi
Journal:  Nature       Date:  2016-08-08       Impact factor: 49.962

5.  Detection of proteinase K resistant proteins in the urine of patients with Creutzfeldt-Jakob and other neurodegenerative diseases.

Authors:  Reza Dabaghian; Inga Zerr; Uta Heinemann; Gianluigi Zanusso
Journal:  Prion       Date:  2008 Oct-Dec       Impact factor: 3.931

6.  Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease.

Authors:  Alexander H Peden; Diane L Ritchie; Mark W Head; James W Ironside
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

7.  Prion type 2 selection in sporadic Creutzfeldt-Jakob disease affecting peripheral ganglia.

Authors:  Anna Hofmann; Arne Wrede; Wiebke M Jürgens-Wemheuer; Walter J Schulz-Schaeffer
Journal:  Acta Neuropathol Commun       Date:  2021-11-24       Impact factor: 7.801

8.  Graft-related disease progression in dura mater graft-associated Creutzfeldt-Jakob disease: a cross-sectional study.

Authors:  Kenji Sakai; Tsuyoshi Hamaguchi; Moeko Noguchi-Shinohara; Ichiro Nozaki; Ichiro Takumi; Nobuo Sanjo; Yosikazu Nakamura; Tetsuyuki Kitamoto; Nobuhito Saito; Hidehiro Mizusawa; Masahito Yamada
Journal:  BMJ Open       Date:  2013-08-23       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.